Latest filing published 12 Jul 2023 for Sensei Biotherapeutics, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Kristian Humer: trading record in brief
Kristian Humer, listed as board member, appears in our data through filings on Faeth Therapeutics, Inc. shares, published by SEC (Form 4). We count 2 filings; the first trade dates from 10 June 2022 and the latest from 10 July 2023.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 12 July 2023, the filings show a share grant in Faeth Therapeutics, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Kristian Humer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,466 shares0Common StockSEC:0001209191-23-042098:0
- 4,466 shares0Common StockSEC:0001209191-22-036667:0
2 of 2 declarations
